User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
  Citation Number 10
 Views 18
 Downloands 5
Anjiotensin dönüştürücü enzim ve I/D polimorfizmi
2005
Journal:  
SDÜ Tıp Fakültesi Dergisi
Author:  
Abstract:

SüleymanDemirel Üniversitesi TIP FAKÜLTESİ DERGİSİ: 2005 Aralık; 12(4) Anjiotensin dönüştürücü enzim ve I/D polimorfizmi Sebahat Turgut Özet Renin-anjiotensin sisteminin kardiovasküler hastalıkların patogenezinde rolü bulunmaktadır ve kalp yetmezliği ile hipertansiyon tedavisinde kullanılan anjiotensin dönüştürücü enzim (ADE) inhibitörleri kardiovasküler sistemde ADE'nin önemli rolünü vurgulamaktadır. Bu yazı ile ADE ve I/D polimorfizmi bilgileri derlenmiştir. ADE, anjiotensin I'i kuvvetli bir vazokonstriktör olan anjiotensin II'e dönüştürür ve bradikininin etkinliğini azaltır. ADE geni insan 17.kromozomunda intron 16'da üç genotip olarak eksprese olur. Bu genotipler “insertion” ve “deletion” olarak isimlendirilen I ve D alelleridir. D aleli, koroner kalp hastalığı ve ventriküler hipertrofi gibi birçok patolojik durumun gelişme riskinde artışla ilişkilidir. D alelli homozigot kişiler birçok kardiak durumda kötü bir prognoza sahiptir. I aleli ise sporcularda dayanıklılık performanslarında artış ile ilişkilidir. Anahtar kelimeler: Anjiotensin dönüştürücü enzim, ADE I/D polimorfizmi, kardiovasküler hastalıklar Abstract Angiotensin Converting Enzyme and I/D Polymorphism The renin-angiotensin system plays a role in the pathogenesis of cardiovascular diseases and the efficacy of angiotensin converting enzyme (ACE) inhibitors in the treatment of hypertension and heart failure emphasize the prominent role of ACE in the cardiovascular system. This review aims to discuss angiotensin converting enzyme and I/D polymorphism. ACE converts angiotensin I to the potent vasoconstrictor angiotensin II and that degrades bradykinin. ACE gene is located on human chromosome 17 expressing three genotypes within the intron 16 of the related gene structure. These genotypes are classified as I and D alleles which are termed as insertion and deletion, respectively. The D allele has been associated with an increased risk of developing several pathological processes, such as coronary heart disease and ventricular hypertrophy. Several cardiac conditions appear to have a worse prognosis in subjects homozygous for the D allele, whereas the I allele has been associated with enhanced endurance performance in sportsmen. Key words: Angiotensin converting enzyme, ACE I/D polymorphism, cardiovascular diseases

Keywords:

Anjiotensin Converter Enzyme and I/D Polymorphism
2005
Author:  
Abstract:

SuleymanDemirel University TIP FACULTY JOURNAL: December 2005; 12(4) Anjiotensin conversion enzyme and I/D polymorphism Sebahat Turgut Summary Renin-anjiotensin system plays a role in the pathogenesis of cardiovascular diseases and angiotensin conversion enzyme (ADE) inhibitors used in the treatment of heart failure and hypertension emphasize the important role of ADE in the cardiovascular system. In this article, the ADE and I/D polymorphism information is collected. ADE turns anjiotensin I into anjiotensin II, a strong vasoconstrictor, and reduces the effectiveness of bradicine. ADE genes are expressed in the human chromosome 17 in three genotypes in the intron 16. These genotypes are allels I and D, which are called "insertion" and "deletion". D alelium is associated with an increased risk of developing many pathological conditions, such as coronary heart disease and ventricular hypertrophy. Homozigot people with D allies have a bad prognosis in many heart cases. It is associated with an increase in the performance of the athletes. Keywords: Angiotensin Converter Enzyme, ADE I/D polymorphism, cardiovascular diseases Abstract Angiotensin Converting Enzyme and I/D Polymorphism The renin-angiotensin system plays a role in the pathogenesis of cardiovascular diseases and the effectiveness of angiotensin Converter Enzyme (ACE) inhibitors in the treatment of hypertension and heart failure emphasizes the prominent role of ACE in the cardiovascular system. This review aims to discuss angiotensin converting enzyme and I/D polymorphism. ACE converts angiotensin I to the potent vasoconstrictor angiotensin II and that degrades bradykin. ACE gene is located on human chromosome 17 expressing three genotypes within the intron 16 of the related gene structure. These genotypes are classified as I and D alleles which are referred to as insertion and deletion, respectively. The D allele has been associated with an increased risk of developing several pathological processes, such as coronary heart disease and ventricular hypertrophy. Several heart conditions appear to have a worse prognosis in subjects homozygous for the D allele, whereas the I allele has been associated with enhanced endurance performance in sportsmen. Key words: Angiotensin converting enzyme, ACE I/D polymorphism, cardiovascular diseases

Keywords:

Citation Owners
Attention!
To view citations of publications, you must access Sobiad from a Member University Network. You can contact the Library and Documentation Department for our institution to become a member of Sobiad.
Off-Campus Access
If you are affiliated with a Sobiad Subscriber organization, you can use Login Panel for external access. You can easily sign up and log in with your corporate e-mail address.
Similar Articles












SDÜ Tıp Fakültesi Dergisi

Field :   Sağlık Bilimleri

Journal Type :   Uluslararası

Metrics
Article : 1.081
Cite : 2.215
2023 Impact : 0.045
SDÜ Tıp Fakültesi Dergisi